CIK 0001665988 · Accelerated filer<br>Emerging growth company
Bioventus Inc.
Sign in to watch- Ticker
- BVS
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 810980861
- Phone
- (919) 474-6700
- Business address
- 4721 EMPEROR BOULEVARD, SUITE 100, DURHAM, NC, 27703
- 8-K Event Results of operations
- 4 Open-market sale SVP & CFO sold 6,044 shares at $1.27 ($7,676)
- 4 Option exercise SVP & CFO acquired 18,625 shares (option exercise)
- 4 Open-market sale SVP & General Counsel sold 3,409 shares at $1.39 ($4,737)
- 4 Option exercise Director acquired 3,949 shares (option exercise)
- 4 Open-market sale Chief Executive Officer sold 9,811 shares at $1.39 ($13,625)
- 4 Open-market sale SVP & Chief Compliance Officer sold 1,332 shares at $1.39 ($1,850)
- NT 10-K Other NT 10-K
- 8-K Event Acquisition or sale completed
- 8-K Event Material agreement · Regulation FD disclosure
- SC 13G Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- 8-K Event Exit or restructuring costs
- 8-K/A Event Results of operations
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- NT 10-Q Other NT 10-Q
Page 14 of 24 · 463 filings